The global TD (Tetanus and Diphtheria) vaccine market is experiencing significant momentum. With a market size of USD 6.17 billion in 2024, projected to grow to USD 10.68 billion by 2034 at a CAGR of 5.64%, the industry is driven by rising incidences of tetanus and diphtheria, awareness campaigns, and advancements in combination vaccines.

Market Overview

The TD vaccine market plays a vital role worldwide, particularly in lower-income countries where tetanus and diphtheria cases remain a challenge. Regulatory bodies like WHO and UNICEF are amplifying efforts to increase vaccination among pregnant women and infants, boosting demand. The rise of Tdap vaccines, which combine protection against tetanus, diphtheria, and pertussis, is streamlining vaccination schedules for adolescents and adults.

Key Market Insights

• Market Size (2024): USD 6.17 billion

• Projected Size (2034): USD 10.68 billion

• CAGR (2025-2034): 5.64%

• Asia Pacific Market Share (2024): 39%

• Fastest-Growing Region: Africa (2025–2034)

• Top Segment (2024): Monovalent TD vaccines (61% share)

• Emerging Segment: Combination vaccines

---

Top TD Vaccine Companies Driving Growth

1. Sanofi Pasteur

• About: The vaccines division of Sanofi, a global healthcare giant headquartered in France.

• Products: Td vaccine, Tdap vaccine (Adacel), pediatric and adult immunizations.

• Market Cap: Approx. USD 140 billion.

2. GlaxoSmithKline (GSK)

• About: A UK-based pharmaceutical and biotechnology leader with strong vaccine development capabilities.

• Products: Boostrix (Tdap), Infanrix, other combination vaccines.

• Market Cap: Approx. USD 80 billion.

3. Serum Institute of India Pvt. Ltd.

• About: The world’s largest vaccine manufacturer by volume, based in India.

• Products: Td vaccine, DTP, and combination vaccines.

• Market Cap: Private company, estimated revenue USD 2 billion+ annually.

4. Biological E. Limited

• About: An Indian biopharmaceutical company with a strong presence in vaccines and biologics.

• Products: Td vaccine, Tdap formulations, pentavalent vaccines.

• Market Cap: Private company, rapidly expanding in global markets.

5. Bharat Biotech International Ltd.

• About: Renowned Indian biotech firm, innovating across vaccines and biotherapeutics.

• Products: Bio-TT, pentavalent vaccines, Tdap pipeline.

• Market Cap: Private company, estimated revenue USD 500 million+ annually.

6. Panacea Biotec Ltd.

• About: Indian biopharma firm focusing on vaccines, biosimilars, and specialty pharmaceuticals.

• Products: EasyFive-TT (pentavalent vaccine), Td formulations.

• Market Cap: Approx. USD 100 million.

7. Pfizer Inc.

• About: A U.S.-based multinational pharma company known for its innovations in vaccines.

• Products: Adacel (Tdap), pediatric vaccines portfolio.

• Market Cap: Approx. USD 160 billion.

8. Merck & Co., Inc.

• About: U.S. pharmaceutical leader, also known as MSD outside North America.

• Products: Td and Tdap vaccines, pediatric immunizations.

• Market Cap: Approx. USD 300 billion.

9. Emergent BioSolutions Inc.

• About: U.S.-based company focusing on vaccines and biodefense solutions.

• Products: Td and Tdap vaccines, specialty biologics.

• Market Cap: Approx. USD 500 million.

10. Microgen (Russia)

• About: Russia’s leading vaccine producer with global exports.

• Products: Td vaccines, DTP, and combination immunizations.

• Market Cap: State-owned, revenue estimated USD 100 million+.

11. PT Bio Farma (Indonesia)

• About: Indonesia’s state-owned vaccine manufacturer with WHO prequalified facilities.

• Products: Td vaccines, DTP, pentavalent vaccines.

• Market Cap: State-owned, key regional supplier in Southeast Asia.

12. Chengdu Institute of Biological Products

• About: Chinese vaccine producer under CNBG (China National Biotec Group).

• Products: Td vaccines, combination vaccines, pediatric vaccines.

• Market Cap: Part of CNBG, a state enterprise.

13. Sinovac Biotech Ltd.

• About: A leading Chinese biopharmaceutical company, globally recognized for COVID-19 vaccines.

• Products: Td vaccines, pediatric immunizations, combination vaccines.

• Market Cap: Approx. USD 7 billion.

14. Haffkine Bio-Pharmaceutical Corporation Ltd.

• About: India-based public sector vaccine manufacturer.

• Products: Td vaccines, pediatric immunizations.

• Market Cap: State-owned, significant presence in domestic immunization programs.

15. Vacsera (Egypt)

• About: Egypt’s national vaccine manufacturer with a focus on regional supply.

• Products: Td vaccines, DTP, combination vaccines.

• Market Cap: State-owned enterprise.

16. LG Chem Ltd. (Korea)

• About: South Korea’s largest chemical company with a growing biopharma division.

• Products: Td vaccines, Tdap, and other biologics.

• Market Cap: Approx. USD 55 billion.

17. Novartis Vaccines (Legacy, now part of GSK)

• About: Former Novartis vaccines portfolio now integrated into GSK.

• Products: Td vaccines, combination immunizations.

• Market Cap (GSK): Approx. USD 80 billion.

---

Market Drivers for TD Vaccine Growth

1. Rising Incidence of Tetanus and Diphtheria

The continued prevalence of these diseases in developing countries underlines the urgent need for vaccination programs.

2. WHO and UNICEF Initiatives

Global organizations are supporting mass immunization campaigns, especially targeting infants and pregnant women.

3. Advancements in Combination Vaccines

Tdap and other multivalent vaccines simplify immunization schedules, encouraging broader adoption.

4. Healthcare Investments in Developing Countries

Strengthening healthcare infrastructure facilitates increased vaccine accessibility and uptake.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com

---

Frequently Asked Questions (FAQs)

Q1: What is the TD vaccine market size in 2025?
The TD vaccine market size is projected at USD 6.52 billion in 2025.

Q2: Which region holds the largest share of the TD vaccine market?
Asia Pacific led with a 39% market share in 2024.

Q3: Which segment is growing fastest in the TD vaccine market?
The combination vaccines segment is expected to experience rapid growth.

Q4: Who are the top players in the global TD vaccine market?
Key players include Sanofi Pasteur, GSK, Pfizer, Serum Institute of India, and others.

Q5: What is driving TD vaccine demand globally?
Key drivers include disease prevalence, global vaccination programs, and advances in combination vaccines.

Source : https://www.towardshealthcare.com/insights/td-vaccine-market-sizing

Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5844